Mackenzie Financial Corp Purchases 44,636 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Mackenzie Financial Corp increased its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 225.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,433 shares of the company's stock after acquiring an additional 44,636 shares during the period. Mackenzie Financial Corp owned about 0.17% of Viemed Healthcare worth $517,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of VMD. SG Americas Securities LLC increased its position in Viemed Healthcare by 193.1% during the fourth quarter. SG Americas Securities LLC now owns 35,579 shares of the company's stock worth $285,000 after buying an additional 23,442 shares during the last quarter. Rhumbline Advisers grew its holdings in shares of Viemed Healthcare by 15.5% during the 4th quarter. Rhumbline Advisers now owns 46,836 shares of the company's stock valued at $376,000 after purchasing an additional 6,275 shares during the last quarter. Rice Hall James & Associates LLC bought a new position in shares of Viemed Healthcare in the 4th quarter valued at $2,083,000. Bailard Inc. bought a new position in shares of Viemed Healthcare during the fourth quarter valued at $255,000. Finally, Bard Associates Inc. lifted its holdings in Viemed Healthcare by 1.3% during the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock worth $2,803,000 after buying an additional 4,474 shares during the period. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Trading Down 4.1%

Shares of NASDAQ:VMD traded down $0.28 during midday trading on Thursday, reaching $6.59. The company's stock had a trading volume of 186,205 shares, compared to its average volume of 139,850. The firm has a market capitalization of $260.46 million, a price-to-earnings ratio of 24.41 and a beta of 1.38. Viemed Healthcare, Inc. has a fifty-two week low of $6.14 and a fifty-two week high of $9.81. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a 50 day moving average price of $6.79 and a two-hundred day moving average price of $7.63.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share for the quarter, meeting analysts' consensus estimates of $0.06. The company had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.